Hans Minderman

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Regulatory T Cells

Top Venues

Cancer immunology research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Sabah Alaklabi, Orla Maguire, Harsha Pattnaik, Yali Zhang, Jacky Chow, Jianmin Wang, Hans Minderman, Renuka Iyer
Immune Cell Molecular Pharmacodynamics of Lanreotide in Relation to Treatment Response in Patients with Gastroenteropancreatic Neuroendocrine Tumors. Cancers 16 (17) (2024)
Bowen Dong, Natasa Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy M Bonura, Cindy Sander, Henry G Withers, Mark D Long, Colin Chavel, Scott H Olejniczak, Hans Minderman, Joanne M Jeter, Robert P Edwards, Walter J Storkus, Pedro Romero, Pawel Kalinski
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs. Cancer immunology research (2024)
Bowen Dong, Natasa Obermajer, Takemasa Tsuji, Junko Matsuzaki, Cindy M Bonura, Cindy Sander, Henry G Withers, Mark D Long, Colin Chavel, Scott H Olejniczak, Hans Minderman, Joanne M Jeter, Robert P Edwards, Walter J Storkus, Pedro Romero, Pawel Kalinski
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs. Cancer immunology research (2024)
Takaaki Oba, Mark D Long, Tibor Keler, Henry C Marsh, Hans Minderman, Scott I Abrams, Song Liu, Fumito Ito
Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s. Nature communications 11 (1) (2020)